Ciro Mercurio

5PUBLICATIONS
119CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 22, 2025
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.

Gabriele Varano, Silvia Lonardi, Paola Sindaco

|Aug 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.

Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi

|Nov 29, 2023
GTF2I dosage regulates neuronal differentiation and social behavior in 7q11.23 neurodevelopmental disorders.

Alejandro López-Tobón, Reinald Shyti, Carlo Emanuele Villa

|Nov 05, 2023
Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.

Ilaria Rosso, Corey Jones-Weinert, Francesca Rossiello

|Dec 08, 2021
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response.

Stefania Faletti, Daniela Osti, Elena Ceccacci

Pageof 1